These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31272725)
1. Late Gadolinium Hyperintensity of Suspected Colorectal Liver Metastases on Gadofosveset-Enhanced Magnetic Resonance Imaging: A Predictor of Benignity and a Potential Problem-Solving Tool. Cheung HMC; Karanicolas PJ; Coburn N; Law C; Milot L Can Assoc Radiol J; 2019 Aug; 70(3):239-245. PubMed ID: 31272725 [TBL] [Abstract][Full Text] [Related]
2. Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy. Cheung HMC; Karanicolas PJ; Hsieh E; Coburn N; Maraj T; Kim JK; Elhakim H; Haider MA; Law C; Milot L Eur Radiol; 2018 Aug; 28(8):3505-3512. PubMed ID: 29476216 [TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases. Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168 [TBL] [Abstract][Full Text] [Related]
4. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232 [TBL] [Abstract][Full Text] [Related]
5. Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience. Milot L; Haider M; Foster L; McGregor C; Law C J Magn Reson Imaging; 2012 Sep; 36(3):738-42. PubMed ID: 22488745 [TBL] [Abstract][Full Text] [Related]
6. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging. Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002 [TBL] [Abstract][Full Text] [Related]
7. P03277-A New Approach to Achieve High-Contrast Enhancement: Initial Results of an Experimental Extracellular Gadolinium-Based Magnetic Resonance Contrast Agent. Fries P; Müller A; Seidel R; Robert P; Denda G; Menger MD; Schneider G; Buecker A Invest Radiol; 2015 Dec; 50(12):835-42. PubMed ID: 26186281 [TBL] [Abstract][Full Text] [Related]
8. Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay. Cheung HM; Law C; Shoichet M; Karanicolas PJ; Coburn N; Milot L Can Assoc Radiol J; 2016 Aug; 67(3):242-9. PubMed ID: 27318891 [No Abstract] [Full Text] [Related]
10. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer. Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases. Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616 [TBL] [Abstract][Full Text] [Related]
12. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases. Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499 [TBL] [Abstract][Full Text] [Related]
13. Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial. Hammerstingl R; Adam G; Ayuso JR; Van Beers B; Belfiore G; Bellin MF; Bongartz G; Ernst O; Frericks B; Giuseppetti G; Heinz-Peer G; Laghi A; Martin J; Pering C; Reimer P; Richter GM; Roemer FW; Schäfer FK; Vilgrain V; Vogl TJ; Weishaupt D; Wall A; Zech CJ; Tombach B Invest Radiol; 2009 Mar; 44(3):168-76. PubMed ID: 19169143 [TBL] [Abstract][Full Text] [Related]
14. Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients. Cheung HMC; Kim JK; Hudson J; Coburn N; Karanicolas PJ; Law C; Milot L Eur Radiol; 2019 Jul; 29(7):3901-3907. PubMed ID: 30937587 [TBL] [Abstract][Full Text] [Related]
15. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI]. Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107 [TBL] [Abstract][Full Text] [Related]
16. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent. Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441 [TBL] [Abstract][Full Text] [Related]
17. Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan. Jhaveri KS; Fischer SE; Hosseini-Nik H; Sreeharsha B; Menezes RJ; Gallinger S; Moulton CE HPB (Oxford); 2017 Nov; 19(11):992-1000. PubMed ID: 28760631 [TBL] [Abstract][Full Text] [Related]
18. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging. Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659 [TBL] [Abstract][Full Text] [Related]
19. Albumin-binding MR blood pool contrast agent improves diagnostic performance in human brain tumour: comparison of two contrast agents for glioblastoma. Puig J; Blasco G; Essig M; Daunis-I-Estadella J; Laguillo G; Quiles AM; Remollo S; Bergmann K; Joly C; Bernado L; Sánchez-González J; Pedraza S Eur Radiol; 2013 Apr; 23(4):1093-101. PubMed ID: 23085863 [TBL] [Abstract][Full Text] [Related]
20. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]